poisar

Stocks · News reference

Barclays Maintains Buy Rating and $70 Price Target for 10x Genomics

Fiscal.ai

Barclays analyst Luke Sergott has reaffirmed a Buy rating and a $70 price target for 10x Genomics, Inc.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading